(3S,5R)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-1-(1-methylpyrazol-4-yl)-3-prop-2-enylpiperidin-2-one

C25H25Cl2N3O — CID 58573830

IUPAC(3S,5R)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-1-(1-methylpyrazol-4-yl)-3-prop-2-enylpiperidin-2-one
SMILESC=CC[C@@]1(C)C[C@H](c2cccc(Cl)c2)C(c2ccc(Cl)cc2)N(c2cnn(C)c2)C1=O
InChIInChI=1S/C25H25Cl2N3O/c1-4-12-25(2)14-22(18-6-5-7-20(27)13-18)23(17-8-10-19(26)11-9-17)30(24(25)31)21-15-28-29(3)16-21/h4-11,13,15-16,22-23H,1,12,14H2,2-3H3/t22-,23?,25+/m1/s1
InChIKeyLOWKZYWCJPTRIM-XOTJBQCQSA-N
MW454.40 g/mol
LogP6.57
Rot. Bonds5

About (3S,5R)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-1-(1-methylpyrazol-4-yl)-3-prop-2-enylpiperidin-2-one

(3S,5R)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-1-(1-methylpyrazol-4-yl)-3-prop-2-enylpiperidin-2-one (PubChem CID 58573830) has the molecular formula C25H25Cl2N3O and a molecular weight of 454.40 g/mol. Its IUPAC name is (3S,5R)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-1-(1-methylpyrazol-4-yl)-3-prop-2-enylpiperidin-2-one.

Molecular Properties

Compound Name(3S,5R)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-1-(1-methylpyrazol-4-yl)-3-prop-2-enylpiperidin-2-one
PubChem CID58573830
Molecular FormulaC25H25Cl2N3O
Molecular Weight454.40 g/mol
Exact Mass453.14
IUPAC Name(3S,5R)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-1-(1-methylpyrazol-4-yl)-3-prop-2-enylpiperidin-2-one
SMILESC=CC[C@@]1(C)C[C@H](c2cccc(Cl)c2)C(c2ccc(Cl)cc2)N(c2cnn(C)c2)C1=O
InChIInChI=1S/C25H25Cl2N3O/c1-4-12-25(2)14-22(18-6-5-7-20(27)13-18)23(17-8-10-19(26)11-9-17)30(24(25)31)21-15-28-29(3)16-21/h4-11,13,15-16,22-23H,1,12,14H2,2-3H3/t22-,23?,25+/m1/s1
InChIKeyLOWKZYWCJPTRIM-XOTJBQCQSA-N
XLogP6.57
TPSA38.13 Ų
H-Bond Donors
H-Bond Acceptors3
Rotatable Bonds5
Heavy Atoms31
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500454.40
LogP ≤ 56.57
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 103

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze (3S,5R)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-1-(1-methylpyrazol-4-yl)-3-prop-2-enylpiperidin-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (3S,5R)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-1-(1-methylpyrazol-4-yl)-3-prop-2-enylpiperidin-2-one?
The IUPAC name of (3S,5R)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-1-(1-methylpyrazol-4-yl)-3-prop-2-enylpiperidin-2-one (CID 58573830) is (3S,5R)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-1-(1-methylpyrazol-4-yl)-3-prop-2-enylpiperidin-2-one.
What is the SMILES notation for (3S,5R)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-1-(1-methylpyrazol-4-yl)-3-prop-2-enylpiperidin-2-one?
The canonical SMILES for (3S,5R)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-1-(1-methylpyrazol-4-yl)-3-prop-2-enylpiperidin-2-one is C=CC[C@@]1(C)C[C@H](c2cccc(Cl)c2)C(c2ccc(Cl)cc2)N(c2cnn(C)c2)C1=O.
What is the InChIKey of (3S,5R)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-1-(1-methylpyrazol-4-yl)-3-prop-2-enylpiperidin-2-one?
The InChIKey is LOWKZYWCJPTRIM-XOTJBQCQSA-N. The full InChI is InChI=1S/C25H25Cl2N3O/c1-4-12-25(2)14-22(18-6-5-7-20(27)13-18)23(17-8-10-19(26)11-9-17)30(24(25)31)21-15-28-29(3)16-21/h4-11,13,15-16,22-23H,1,12,14H2,2-3H3/t22-,23?,25+/m1/s1.
What are the key properties of (3S,5R)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-1-(1-methylpyrazol-4-yl)-3-prop-2-enylpiperidin-2-one?
(3S,5R)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-1-(1-methylpyrazol-4-yl)-3-prop-2-enylpiperidin-2-one has a molecular weight of 454.40 g/mol, XLogP of 6.57, 5 rotatable bonds, 0 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for (3S,5R)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-1-(1-methylpyrazol-4-yl)-3-prop-2-enylpiperidin-2-one is sourced from PubChem (CID 58573830), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).